Abstract
We have shown that an unusual morphological thinning of the anterior clear zone of the lens is found in patients with gout on long term Allopurinol therapy. The significance of this is discussed.
Similar content being viewed by others
Article PDF
References
Cameron JS and Simmonds HA : Use and abuse of Allopurinol. Br Med J 1987, 294: 1504–5.
Cameron JS and Simmonds HA : Correction: Use and Abuse of Allopurinol. Br Med J 1987, 295: 350.
Fraunfelder FT, Hanna C, Dreis MW, Cosgrove KW Jr: Cataracts associated with Allopurinol therapy. Am J Ophthalmol 1982, 94: 137–209.
Lerman S, Megaw JM, Gardner K : Allopurinol therapy and cataractogenesis in humans. Am J Ophthalmol 1982, 94: 141–6.
Lerman S, Megaw J, Fraunfelder FT : Further studies on Allopurinol therapy and human cataractogenesis. Am J Ophthalmol 1984, 97: 205–9.
Harding JJ and van Heyningen R : Epidemiology and risk factors for Cataract. Eye 1987, 1: 537–41.
Sparrow JM, Bron AJ, Brown NAP, Ayliffe W, Hill AR : The Oxford Clinical Cataract Classification and Grading System. Int Ophthalmol 1986, 9: 207–55.
Brown NAP, Bron AJ, Ayliffe W, Sparrow J, Hill AR : The objective assessment of cataract. Eye 1987, 1: 234–46.
Brown NAP and Tripathi R : Loss of the anterior subcapsular clear zone of the lens. Prognostic significance in cataract formation. Trans. Ophthalmol Soc UK. 1974, 74: 29–45.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, C., Brown, N., Leonard, T. et al. The prevalence and morphology of cataract in patients on Allopurinol treatment. Eye 2, 600–606 (1988). https://doi.org/10.1038/eye.1988.112
Issue Date:
DOI: https://doi.org/10.1038/eye.1988.112